Chandrani Bose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chandrani Bose has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anirban Dutta
TCS Research, Tata Consultancy Services Limited, Pune, Maharashtra, India
1 shared publication - Binuja Varma
TCS Genomics Lab, Tata Consultancy Services Limited, Noida, Uttar Pradesh, India 201313
1 shared publication - Jaya M. Satagopan
Department of Biostatistics and Epidemiology & Center for South Asian Quantitative Health and Education, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, USA
1 shared publication - Krishna Sukla
Life Sciences R&I, TCS Research, Tata Consultancy Services Limited, Hinjewadi Phase-III, Pune, India
1 shared publication - Mohammed Monzoorul Haque
Life Sciences R&I, TCS Research, Tata Consultancy Services Limited, Hinjewadi Phase-III, Pune, India
1 shared publication - Natalia Gontarczyk Uczkowski
Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, USA
1 shared publication
Latest Publications
- Open Access
- 30 August 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation
Breast cancer, the most common cancer in women worldwide, is linked to microbiome imbalances. This suggests the potential for microbiome-based breast cancer management. However, a comprehensive and reproducible understanding of the microbiome’s role in breast cancer is lacking. We conducted a systematic literature review to explore microbiome signatures and specific genera associated with breast cancer development, subtypes, and outcomes. We searched PubMed, Embase, Scopus, and Web of Science using the terms “microbiome” and “breast cancer”, limiting to publications of human studies in English language between January 2011 and January 2025, and adhering to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. We extracted the study characteristics and results and summarized our findings. From 2536 articles, we identified 48 eligible studies – 22 case-control, 13 cohorts without any intervention, and 13 cohorts with an intervention. These studies included 3735 women with and 2023 without a diagnosis of breast cancer. Most studies used fecal (29) or breast tissue (14) samples. The genera Clostridium, Lcatobacillus, Prevotella were most commonly associated with breast cancer. However, no genus was consistently linked to the same outcome across studies, rendering meta-analysis unfeasible. Overall, we observed heterogenous methods for data generation and computational analysis leading to challenges in comparative analysis. While several genera are linked to breast cancer, the findings lack consistency across studies. Future studies should employ standardized outcomes, data collection, and processing methods to establish reproducible microbial markers to develop effective microbiome-based breast cancer management strategies.
- 30 August 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Open AccessBreast cancer and microbiome: a systematic review highlighting challenges for clinical translation
Breast cancer, the most common cancer in women worldwide, is linked to microbiome imbalances. This suggests the potential for microbiome-based breast cancer management. However, a comprehensive and reproducible understanding of the microbiome’s role in breast cancer is lacking. We conducted a systematic literature review to explore microbiome signatures and specific genera associated with breast cancer development, subtypes, and outcomes. We searched PubMed, Embase, Scopus, and Web of Science using the terms “microbiome” and “breast cancer”, limiting to publications of human studies in English language between January 2011 and January 2025, and adhering to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. We extracted the study characteristics and results and summarized our findings. From 2536 articles, we identified 48 eligible studies – 22 case-control, 13 cohorts without any intervention, and 13 cohorts with an intervention. These studies included 3735 women with and 2023 without a diagnosis of breast cancer. Most studies used fecal (29) or breast tissue (14) samples. The genera Clostridium, Lcatobacillus, Prevotella were most commonly associated with breast cancer. However, no genus was consistently linked to the same outcome across studies, rendering meta-analysis unfeasible. Overall, we observed heterogenous methods for data generation and computational analysis leading to challenges in comparative analysis. While several genera are linked to breast cancer, the findings lack consistency across studies. Future studies should employ standardized outcomes, data collection, and processing methods to establish reproducible microbial markers to develop effective microbiome-based breast cancer management strategies.
- Open Access
- 20 August 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (8) , e0021125
Nucleomodulins from gut bacteria: diverse mechanisms of translocation and interaction with host nuclear processes
Nucleomodulins (NMs) are bacterial nuclear-targeted effector proteins that interfere with a multitude of host cellular processes to shield pathogens from host immune responses. Recent years observed a surge in NM-related research owing to their potential role in both infectious diseases and cancer development. However, considering the complex nature of the interaction between NM and host factors, the field of “NM-disease axis” is still in the nascent phase. Thus, a comprehensive view of the known mechanisms of translocation of NMs to the host cell nucleus and mode of action, thereafter, is crucial toward deeper exploration of the “NM-disease axis.” The human gut is the major host niche to harbor bacterial cells (as part of “gut microbiota”). The current review provides an extensive collation of nucleomodulin-mediated mechanisms employed by opportunistic gut pathogens. The insights from the review would help in designing future experiments toward utilizing the NM-associated host-pathogen interaction modules in disease diagnostics and therapy.
- 20 August 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (8) , e0021125
Open AccessNucleomodulins from gut bacteria: diverse mechanisms of translocation and interaction with host nuclear processes
Nucleomodulins (NMs) are bacterial nuclear-targeted effector proteins that interfere with a multitude of host cellular processes to shield pathogens from host immune responses. Recent years observed a surge in NM-related research owing to their potential role in both infectious diseases and cancer development. However, considering the complex nature of the interaction between NM and host factors, the field of “NM-disease axis” is still in the nascent phase. Thus, a comprehensive view of the known mechanisms of translocation of NMs to the host cell nucleus and mode of action, thereafter, is crucial toward deeper exploration of the “NM-disease axis.” The human gut is the major host niche to harbor bacterial cells (as part of “gut microbiota”). The current review provides an extensive collation of nucleomodulin-mediated mechanisms employed by opportunistic gut pathogens. The insights from the review would help in designing future experiments toward utilizing the NM-associated host-pathogen interaction modules in disease diagnostics and therapy.
- Open Access
- 27 July 2018
- Published by Springer Nature in BMC Genomics
- Vol. 19 (1) , 555
Understanding the role of interactions between host and Mycobacterium tuberculosis under hypoxic condition: an in silico approach
Mycobacterium tuberculosis infection in humans is often associated with extended period of latency. To adapt to the hostile hypoxic environment inside a macrophage, M. tuberculosis cells undergo several physiological and metabolic changes. Previous studies have mostly focused on inspecting individual facets of this complex process. In order to gain deeper insights into the infection process and to understand the coordination among different regulatory/ metabolic pathways in the pathogen, the current in silico study investigates three aspects, namely, (i) host-pathogen interactions (HPIs) between human and M. tuberculosis proteins, (ii) gene regulatory network pertaining to adaptation of M. tuberculosis to hypoxia and (iii) alterations in M. tuberculosis metabolism under hypoxic condition. Subsequently, cross-talks between these components have been probed to evaluate possible gene-regulatory events as well as HPIs which are likely to drive metabolic changes during pathogen’s adaptation to the intra-host hypoxic environment. The newly identified HPIs suggest the pathogen’s ability to subvert host mediated reactive oxygen intermediates/ reactive nitrogen intermediates (ROI/ RNI) stress as well as their potential role in modulating host cell cycle and cytoskeleton structure. The results also indicate a significantly pronounced effect of HPIs on hypoxic metabolism of M. tuberculosis. Findings from the current study underscore the necessity of investigating the infection process from a systems-level perspective incorporating different facets of intra-cellular survival of the pathogen. The comprehensive host-pathogen interaction network, a Boolean model of M. tuberculosis H37Rv (Mtb) hypoxic gene-regulation, as well as a genome scale metabolic model of Mtb, built for this study are expected to be useful resources for future studies on tuberculosis infection.
- 27 July 2018
- Published by Springer Nature in BMC Genomics
- Vol. 19 (1) , 555
Open AccessUnderstanding the role of interactions between host and Mycobacterium tuberculosis under hypoxic condition: an in silico approach
Mycobacterium tuberculosis infection in humans is often associated with extended period of latency. To adapt to the hostile hypoxic environment inside a macrophage, M. tuberculosis cells undergo several physiological and metabolic changes. Previous studies have mostly focused on inspecting individual facets of this complex process. In order to gain deeper insights into the infection process and to understand the coordination among different regulatory/ metabolic pathways in the pathogen, the current in silico study investigates three aspects, namely, (i) host-pathogen interactions (HPIs) between human and M. tuberculosis proteins, (ii) gene regulatory network pertaining to adaptation of M. tuberculosis to hypoxia and (iii) alterations in M. tuberculosis metabolism under hypoxic condition. Subsequently, cross-talks between these components have been probed to evaluate possible gene-regulatory events as well as HPIs which are likely to drive metabolic changes during pathogen’s adaptation to the intra-host hypoxic environment. The newly identified HPIs suggest the pathogen’s ability to subvert host mediated reactive oxygen intermediates/ reactive nitrogen intermediates (ROI/ RNI) stress as well as their potential role in modulating host cell cycle and cytoskeleton structure. The results also indicate a significantly pronounced effect of HPIs on hypoxic metabolism of M. tuberculosis. Findings from the current study underscore the necessity of investigating the infection process from a systems-level perspective incorporating different facets of intra-cellular survival of the pathogen. The comprehensive host-pathogen interaction network, a Boolean model of M. tuberculosis H37Rv (Mtb) hypoxic gene-regulation, as well as a genome scale metabolic model of Mtb, built for this study are expected to be useful resources for future studies on tuberculosis infection.